Title:
4-AMINOPYRIDINE DERIVATIVE
Document Type and Number:
Japanese Patent JP2017206437
Kind Code:
A
Abstract:
PROBLEM TO BE SOLVED: To provide a new compound having fibroblast growth factor receptor (FGFR) inhibitory action, and a pharmaceutical composition containing the same.SOLUTION: The present invention provides a compound represented by formula (I) or pharmaceutically acceptable salt thereof [A is a Carylene group; J is a Cnitrogen-containing nonaromatic heterocyclic group that may have one-three substituent selected from a substituent group L, or the like; R, R, and Rare a hydrogen atom or the like; Ris a Calkyl group; Ris a hydroxy Calkyl group that may be substituted with one-three halogen atom, or the like; R, R, R, R, and Rare a hydrogen atom or the like; the substituent group L is a group consisting of a Calkyl group and the like].SELECTED DRAWING: None
Inventors:
FUNASAKA SETSUO
OKADA TOSHIMI
NAGAO SATOSHI
OHASHI ISAO
NAKATANI YUSUKE
KARAUSHI YUKI
OKADA TOSHIMI
NAGAO SATOSHI
OHASHI ISAO
NAKATANI YUSUKE
KARAUSHI YUKI
Application Number:
JP2014166119A
Publication Date:
November 24, 2017
Filing Date:
August 18, 2014
Export Citation:
Assignee:
EISAI R&D MAN CO LTD
International Classes:
C07D401/12; A61K31/4439; A61K31/4545; A61K31/496; A61K31/5377; A61P35/00; A61P43/00; C07D401/14; C07D417/14; C07D451/06; C07D487/08
Attorney, Agent or Firm:
Yoshiki Hasegawa
Yoshinori Shimizu
Kimoto
Junichiro Sakamaki
Yoshinori Shimizu
Kimoto
Junichiro Sakamaki